Abstract
Mice pretreated with the monoamine oxidase inhibitor pargyline showed a dose-dependent increase in hyperactivity for up to 2 h following injections of N,N-dimethyltryptamine (DMT: 0.5–8.0 mg/kg). Hyperactivity was related to a linear increase in whole brain concentrations of DMT as measured by a new sensitive gas chromatographic assay. The duration of this behaviour paralleled the concentration of DMT in the brain from 15–120 min. However, at 15 min, there was no significant difference in brain DMT concentrations between mice receiving pargyline and those given distilled water at the two dose levels of DMT studied (2.0 and 8.0 mg/kg). Pre-treatment with the microsomal enzyme inhibitor SKF-525A, alone or in combination with pargyline, had no effect on the DMT-induced behaviour or on the brain levels of DMT.
Similar content being viewed by others
References
Axelrod J (1962) The enzymatic N-methylation of serotonin and other amines. J Pharmacol Exp Ther 179:236–249
Bailey DN, Guba JJ (1980) Gas-chromatographic analysis for phencyclidine in plasma, with use of a nitrogen detector. Clin Chem 26:437–440
Barker SA, Monti JA, Christian ST (1980) Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates. Biochem Pharmacol 29:1049–1057
Boarder MR, Oon MCH, Rodnight R (1976) Mass spectrometric identification of N-monomethyltryptamine following incubation of tryptamine with brain protein and SAM or 5 MTHF. Biochem Pharmacol 25:2109–2112
Boarder MR, Rodnight R (1976) Tryptamine-N-methyltransferase activity in brain tissue: a re-examination. Brain Res 114:359–364
Cohen I, Vogel WH (1972) Determination and physiological disposition of dimethyltryptamine and diethyltryptamine in rat brain, liver and plasma. Biochem Pharmacol 21:1214–1216
Davis M, Sheard MH (1974) Biphasic dose-response effects of N,N-dimethyltryptamine on the rat startle reflex. Pharmacol Biochem Behav 2:827–829
Erdelyi E, Elliott GR, Wyatt RJ, Barchas JD (1978) S-adenosylmethionine-dependent-N-methyltransferase activity in autopsied brain parts of chronic schizophrenics and controls. Am J Psychiatry 135:725–728
File SE (1977) Effects of N,N-dimethyltryptamine on behavioural habituation in the rat. Pharmacol Biochem Behav 6:163–168
Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DO, Adams LM, Hawkins RL (1979) A characteristic effect of hallucinogens on investigatory responding in rats. Psychopharmacology 65:35–40
Gillin JC, Kaplan J, Stillman R, Wyatt RJ (1976) The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine. Am J Psychiatry 133:203–208
Gillin JC, Stoff DM, Wyatt RJ (1978) Transmethylation hypothesis: a review of progress. In: Lipton MA, Mascio A, Killam KF (eds) Psychopharmacology, a generation of progress, Raven, New York, pp 1097–1112
Gomes UR, Neethling AC, Shanley BC (1976) Enzymatic N-methylation of indoleamines by mammalian brain: fact or artifact. J Neurochem 27:701–705
Jenner P, Marsden CD, Thanki CM (1980) Behavioural changes induced by N,N-dimethyltryptamine in rodents. Br J Pharmacol 69:69–80
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lu LJW, Demtriou SK, Domino EF (1978) Effects of various neuroleptics, phenobarbital and SKF-525A on dimethyltryptamine content in rat brain and liver. Arch Int Pharmacodyn Ther 232:117–133
Mandel LR, Ahn HS, Van Den Heuvel WJA, Walker RW (1972) Indoleamine-N-methyltransferase in human lung. Biochem Pharmacol 21:1197–1200
Mandell AJ, Morgan M (1971) Indole(ethyl)amine N-methyltransferase in human brain. Nature 230:85–87
Morinan A, Rodnight R (1981) An improved semi-micro method for the assay of indolylamine-N-methyltransferase activity in mammalian tissue. Biochem Soc Trans (in press)
Murray RM, Oon MCH, Rodnight R, Birley JLT, Smith A (1979) Increased excretion of dimethyltryptamine and certain features of psychosis. A possible association. Arch Gen Psychiatry 36:644–649
Narasimhachari N, Callison D, Lin R-L (1979) Effect of MAO inhibitors on the tissue distribution of dimethyltryptamine, 5-methoxydimethyltryptamine and bufotenin after their intraperitoneal administration in rat. Res Commun Psychol Psychiat Behav 4:257–268
Oon MCH, Rodnight R (1977) A gas chromatographic procedure for determining N,N-dimethyltryptamine and N-monomethyl-tryptamine in urine using a nitrogen detector. Biochem Med 18:410–419
Saavedra JM, Axelrod J (1972) A specific and sensitive enzymatic assay for tryptamine in tissues. J Pharmacol Exp Ther 182:363–369
Saavedra JM, Coyle JT, Axelrod J (1973) The distribution and properties of the non-specific N-methyltransferase in brain. J Neurochem 20:743–752
Sangiah S, Gomez MV, Domino EF (1979) Accumulation of N,N-dimethyltryptamine in rat brain cortical slices. Biol Psychiatry 14:925–936
Shah NK, Hedden MP (1978) Behavioural effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with β-diethylaminoethyldiphenylpropyl acetate (SKF-525A), iproniazid and chlorpromazine. Pharmacol Biochem Behav 8:351–356
Stramentinoli G, Baldessarini RJ (1978) Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine and S-adenosylmethionine. J Neurochem 31:1015–1020
Walters JK, Sheard MH, Davis M (1978) Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5 MeODMT) on shock-elicited fighting in rats. Pharmacol Biochem Behav 9:87–90
Wyatt RJ, Gillin JC, Kaplan J, Stillman R, Mandel L, Ahn HS, Van Den Heuvel WJA, Walker RW (1974) N,N-dimethyltryptamine — A possible relationship to schizophrenia. In: Costa E, Gessa GL, Sandler ML (eds) Serotonin-new vistas. Raven, New York, pp 299–313
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morinan, A., Collier, J.G. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice. Psychopharmacology 75, 179–183 (1981). https://doi.org/10.1007/BF00432184
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432184